PMN PMN
Company Profile ↓Company Overview
PMN (PMN) is a publicly traded company listed on with a market capitalization of $29.01M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Recent Developments
- Trailing 12 Months Year-on-year growth — earnings -1529.3%.
Growth & Price Performance
Compounded Profit Growth
| 5 Years: | - |
| 1 Year: | -1,529.33% |
Stock Price Performance
| 1 Year: | -22.97% |
| 6 Months: | -15.22% |
| 3 Months: | +21.88% |
| 1 Month: | -0.52% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- Golden Cross2d ago
- RSI (14)51.18 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Trading 45.6% below its 52-week high.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jun 2021 | Sep 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | - | - | - | - | - | - | - | - | - | - | - | - | 7.46M | 10.18M | 11.75M | 10.77M | 8.64M |
| Operating Income | -1.11M | -2.07M | -3.94M | -4.86M | -6.05M | -4.97M | -2.90M | -2.52M | -3.68M | -2.71M | -4.43M | - | -7.46M | -10.18M | -11.75M | -10.77M | -8.64M |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | -7.46M | -10.12M | -11.58M | -10.67M | -8.64M |
| Interest Expense | - | - | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | - |
| Pretax Income | - | - | - | - | - | - | - | - | - | - | - | - | -7.35M | -10.12M | -11.58M | -10.67M | -8.24M |
| Tax Provision | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Income | -225.54K | -1.21M | -2.09M | -2.75M | -5.96M | -4.96M | -2.31M | -2.36M | -3.64M | -2.62M | 9.28M | - | -7.35M | -10.12M | -11.58M | -10.67M | -8.24M |
| Diluted EPS | -0.06 | -0.20 | -0.29 | -0.38 | -0.83 | -0.58 | -0.27 | -0.19 | -0.19 | -0.13 | 0.31 | - | -5.27 | -7.25 | -6.00 | - | -5.27 |
| R&D Expense | 754.30K | 805.39K | 1.90M | 3.23M | 4.57M | 3.51M | 1.01M | 1.14M | 2.12M | 1.63M | 2.56M | - | 5.46M | 8.75M | 9.80M | - | 6.97M |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 0 | 0 | 0 | 0 |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | - | 23.38M | 14.26M | 16.83M | 40.17M |
| Operating Income | - | -23.38M | -14.26M | -16.83M | -40.17M |
| EBITDA | - | -17.77M | -12.99M | 2.86M | -39.72M |
| Interest Expense | - | 282.06K | 201.39K | 76.78K | 0 |
| Pretax Income | - | -18.06M | -13.21M | 2.78M | -39.72M |
| Tax Provision | - | - | - | - | - |
| Net Income | - | -18.06M | -13.21M | 2.78M | -39.72M |
| Diluted EPS | - | -60.25 | -26.75 | 2.63 | -22.61 |
| R&D Expense | 4.63M | 16.09M | 7.88M | 10.64M | 33.38M |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Total Assets | - | - | 6.92M | 13.62M | 18.91M | 9.18M |
| Current Assets | - | - | 6.90M | 13.62M | 18.91M | 9.18M |
| Cash & Equivalents | - | - | 5.88M | 12.60M | 13.29M | 6.12M |
| Inventory | - | - | - | - | - | - |
| Receivables | - | - | 71.63K | 78.64K | 78.03K | 36.52K |
| Total Liabilities | - | - | 8.27M | 9.87M | 2.42M | 10.44M |
| Current Liabilities | - | - | 6.41M | 9.35M | 2.22M | 10.41M |
| Long Term Debt | - | 3.91M | - | - | - | - |
| Total Debt | - | 3.91M | - | - | - | - |
| Total Equity | -796.66K | - | -1.35M | 3.75M | 16.49M | -1.26M |
| Shares Outstanding | - | - | 343.17K | 755.41K | 1.31M | 2.15M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | -17.03M | -10.84M | -27.18M | -28.12M |
| Investing Cash Flow | - | -1.98K | -1.35K | -693 | -702 |
| Financing Cash Flow | - | 6.49M | 17.75M | 27.88M | 20.94M |
| Capital Expenditure | -6.04K | -1.98K | - | - | - |
| Free Cash Flow | - | -17.04M | -10.84M | -27.18M | -28.12M |
| Net Change in Cash | - | -10.54M | 6.90M | 693.02K | -7.17M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | - | - | - | - |
| Operating Margin % | - | - | - | - | - |
| Net Margin % | - | - | - | - | - |
| ROE % | - | 1,340.2% | -352.0% | 16.9% | 3,155.8% |
| ROCE % | - | -4,569.9% | -334.1% | -100.8% | 3,267.2% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for PMN
$PMN stock is up 16% today. Here's what we see in our data. - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMinwFBVV95cUxQRjI3S1ZwOHZ1X1FLeE5DT0xBVWZYd2kzR3dlR1UyTmJxOXpmdUc5V280STdrakszRUl1SU1fNEc1UWRYRUMyUUNndUkyajhlTXVjNjZCMzdVeFlnTnZwdEZXSWpUTU5ULTdsUzVPdWpFcGRsc1hrMlk3TVBFa24yZDNicktyRm9WX0syRW…
ProMIS Neurosciences (NASDAQ:PMN) is undervalued, this analyst says - cantechletter.com
<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxQRnM3YmVCVnZ1eVlJQnh0OC0wOG1NYlc1YS1tOWU4ajUxR1pMZVQxRno3RFFLZ2ZhWGxXeW83T0o0eW1mRGFwdjFLVlc3LVdYemVlU3prRXFwRXc1LVNoLWFRUk5LTURPYUxtNjcyeS1MQVhRZS16SUZmVFdvRjZBdjk1eC15RFlQT1dqTm…
Wall Street Analysts See a 230.23% Upside in Promis Neurosciences (PMN): Can the Stock Really Move This High? - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMimAFBVV95cUxPbU42Z0xNV2pXQ0pXZEtJNWp6Mk85Nm0yQ2g4d3pCREdITkNLY0RTVVF6LUFUN1FydGcwb2xGai1FYXBycUZuZ3BaM0dBZXV1bEVtQVZoOU1iekVBRXRuZVNxRTBfMkxxNjEwWWtlb1NvTzcxbEk2ZGxLOXVTa0JndlJldm5oMTZVZmhNQz…
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxQSEhYbjdydF9JbEVQM3V3UUxvSTNFSjBtRkdsNUhVY0dqY1p4NnczWVVpelQ4S3Rfdlh4SnJDNnYtZXV1c2lRUk5PYkgzNFA0eUpaYXJVRGZLSFdGWXAyN3lacUJ3ZmRRajZ0S21ZLVZ2Mmd6N0x6RHhZQzJMaXMyek9HMGFxbGFFLXo4bG…
ProMIS Neurosciences (PMN) Shares Rally on Promising Alzheimer's Trial Data - GuruFocus
<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxQTUp1UHhNanAwdXdPbFNGRzdOY292SWsyTDhzLWU2QTN3MTFYNzFpcDlJNndmVGJXbmpuR0pJRVhOcDZoZWdoTEhLM0RxM1FCXzFyRHFibFE4TWJBdjF5Q3BXZldTOUlQY19XRWtsUUswUUtGLURIS3NhdFVadS1PaU5PcGwwZERlVlFURk…
PMN|ProMIS Neurosciences Inc|Price:13.720|Chg%:-1.200 - TradingKey
<a href="https://news.google.com/rss/articles/CBMibEFVX3lxTE85NWhXaTZyUHA0bHBqU2VNVE85dEJ0d1dMdE1MTzloV0dwQmxoU2g0M3hjSzRBcWJsSklPR0NpMkE3TFQyYjdJcUxDd0NvZUotTWVvUFBXbTRzZUxwM1dfRlY3WGNzMENDU0w0Yg?oc=5" target="_blank">PMN|ProMIS Neuroscien…
PMN — Frequently Asked Questions
What is the current share price of PMN?
As of 2026-08-05 17:25 PDT, PMN trades at $13.48 on NASDAQ/NYSE. Its 52-week range is $6.76 to $24.79.
What is the market capitalisation of PMN?
PMN has a market capitalisation of $29.01M on NASDAQ/NYSE.
What is the P/E ratio of PMN?
PMN trades at a trailing price-to-earnings (P/E) ratio of -0.60. Its price-to-book (P/B) ratio is -23.05.
Is PMN a good stock to buy?
This page provides a data-driven analysis of PMN, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.